ORCHID PHARMA Fact Sheet, ORCHID PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA Fact Sheet    (ORCHID)


FREE REPLAY: Discover What Richa Revealed in Her Smallcaps Summit


Here is the latest financial fact sheet of ORCHID PHARMA. For more details, see the ORCHID PHARMA quarterly results and ORCHID PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

ORCHID PHARMA Price History

Price Rs 402.0
Mkt Cap Rs m 16,408
Vol '000 2.1
P/E X -17.1
P/CF X -215.5
EPS (TTM) Rs -23.5
% ch % -1.2
No. of shares m 40.82
% ch week % 1.0
% ch 1-mth % -3.9
% ch 12-mth % 877.2
52 week H/L Rs 2,680.0/43.2
(As on Nov 29, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ORCHID PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ORCHID PHARMA EQUITY SHARE DATA
High Rs46401482,465 
Low Rs24113418 
Sales per share (Unadj.) Rs88.376.267.4118.5110.3 
Earnings per share (Unadj.) Rs-55.1-39.77.8-32.1-28.5 
Diluted earnings per shareRs-120.2-86.417.0-32.1-28.5 
Cash flow per share (Unadj.) Rs-39.3-24.722.4-3.2-1.9 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs-43.6-89.0-79.1187.6159.9 
Adj. book value per shareRs-95.0-194.0-172.5187.7160.0 
Shares outstanding (eoy) m88.9688.9688.9640.8240.82 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.40.30.10.111.3 
Avg P/E ratio x-0.6-0.61.1-0.2-43.5 
P/CF ratio (eoy) x-0.9-1.00.4-1.9-665.6 
Price / Book Value ratio x-0.8-0.3-0.107.8 
Dividend payout %00000 
Avg Mkt Cap Rs m3,0962,24974224950,677 
No. of employees `000NANANANANA 
Total wages/salary Rs m803862823749671 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ORCHID PHARMA INCOME DATA
Net Sales Rs m7,8566,7826,0004,8384,501 
Other income Rs m192203169243152 
Total revenues Rs m8,0476,9856,1695,0814,653 
Gross profit Rs m-8562431,891-312294 
Depreciation Rs m1,4101,3331,2991,1791,089 
Interest Rs m3,3113,1036762522 
Profit before tax Rs m-5,385-3,990694-1,311-1,165 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-480-462000 
Profit after tax Rs m-4,905-3,528694-1,311-1,165 
Gross profit margin %-10.93.631.5-6.46.5 
Effective tax rate %8.911.6000 
Net profit margin %-62.4-52.011.6-27.1-25.9 
ORCHID PHARMA BALANCE SHEET DATA
Current assets Rs m8,7916,7897,6755,6935,499 
Current liabilities Rs m15,40720,12523,4551,7491,421 
Net working cap to sales %-84.2-196.6-263.081.590.6 
Current ratio x0.60.30.33.33.9 
Inventory Days Days322424472520 
Debtors Days Days9464735131,101 
Net fixed assets Rs m24,78924,46423,0968,9066,874 
Share capital Rs m890890890408408 
"Free" reserves Rs m-4,766-8,807-7,9307,2526,121 
Net worth Rs m-3,877-7,918-7,0407,6606,529 
Long term debt Rs m21,56818,93914,2465,0404,275 
Total assets Rs m33,58031,25430,77014,59912,373 
Interest coverage x-0.6-0.311.4-20.0-1.2 
Debt to equity ratio x-5.6-2.4-2.00.70.7 
Sales to assets ratio x0.20.20.20.30.4 
Return on assets %-4.7-1.42.5-8.6-5.2 
Return on equity %126.544.6-9.9-17.1-17.8 
Return on capital %-11.7-8.010.6-9.8-6.0 
Exports to sales %71.173.880.091.388.1 
Imports to sales %26.922.628.131.337.3 
Exports (fob) Rs m5,5885,0024,7984,4163,966 
Imports (cif) Rs m2,1171,5341,6881,5141,677 
Fx inflow Rs m5,5885,0024,7984,4163,966 
Fx outflow Rs m2,8452,2531,8641,6051,729 
Net fx Rs m2,7432,7492,9342,8102,237 
ORCHID PHARMA CASH FLOW
From Operations Rs m 3,170 92 120 808 236 
From Investments Rs m -86 -281 455 1,671 672 
From Financial Activity Rs m -3,663 334 -3 -2,503 -1,650 
Net Cashflow Rs m -579 145 572 -24 -742 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 90.0%
Institution 5.2%
Non-Institution 4.8%
Total 100.0%
Free Float 10.0%
Pledged promoter holdings 32.7%
 

Company Information

REGD OFF Orchid Towers, 313 Valluvar Kottam High Road, Nungambakkam, Chennai - 600034
E-MAIL corporate@orchidpharma.com/nikitak@orchidpharma.com WEB www.orchidpharma.com
TEL 044-28211000/2824 4910 / 2824 4355 FAX 044-28211002
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Abhipra Capital Ltd, Abhipra Complex, A-387 Azadpur, Dilkush Indl.Area G T Karnal Road
AUDITOR SNB Associates
CHM: K. Raghavendra Rao (MD) COMP SEC: L. Chandrasekar YEAR OF INC: 1992 BSE CODE: 524372 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   GANGA PHARMACEUTICALS  DENIS CHEM LAB  AJANTA PHARMA  IPCA LABS  CORAL LAB.  

Compare ORCHID PHARMA With:   GANGA PHARMACEUTICALS  DENIS CHEM LAB  AJANTA PHARMA  IPCA LABS  CORAL LAB.  




Today's Market

Sensex Ends 153 Points Higher; Kotak Mahindra Bank & HCL Tech Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally higher.

Views on news

Why Did Orchid Pharma Shares Plunge 10% Today? (Views On News)

Jun 25, 2021

Orchid Pharma shares plunge 10% as company fixes OFS price at 72% discount.

Orchid Pharma Shares Zoom 7,700% in Seven Months. More Gains Ahead? (Views On News)

Jun 3, 2021

Here's why Orchid Pharma shares have rallied 7,700% in seven months.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA

ORCHID PHARMA - EMMESSAR CHM COMPARISON

COMPARE ORCHID PHARMA WITH

MARKET STATS